Literature DB >> 10706632

CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.

M T Zilber1, S Gregory, R Mallone, S Deaglio, F Malavasi, D Charron, C Gelin.   

Abstract

This work analyzes the hypothesis that human CD38 may cooperate with MHC Class II by acting as coreceptor in a superantigen-induced activation. The initial evidence is that CD38 ligation by specific monoclonal antibodies inhibits superantigen-induced T lymphocyte proliferation. Inhibitory effects become apparent after engagement of CD38 expressed by monocytes, whereas ligation of CD38 expressed by T lymphocytes does not apparently affect activation. The inhibition requires a cell-to-cell interaction, followed by the relevant transmembrane signaling that is reproduced by CD38 ligation. Indeed, CD38 ligation on monocytes induces tyrosine phosphorylation of several intracellular proteins including the protooncogene product c-cbl and the fgr and hck tyrosine kinases. The receptorial nature of the CD38-mediated events is confirmed by the observation of an intracellular calcium flux in monocytes secondary to CD38 ligation. These effects are additive with the similar events elicited by MHC Class II ligation, a likely indication that CD38 and MHC Class II share a common activation pathway. This conclusion is strengthened by results of comodulation experiments, indicating that CD38 and MHC Class II display lateral associations on monocytes. These results attribute to CD38 expressed by monocytes a role in the transduction of signal(s) involved in superantigen-induced activation, operating in synergy with MHC Class II.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706632      PMCID: PMC16017          DOI: 10.1073/pnas.050583197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Protein-tyrosine phosphorylation by IgG1 subclass CD38 monoclonal antibodies is mediated through stimulation of the FcgammaII receptors in human myeloid cell lines.

Authors:  S Inoue; K Kontani; N Tsujimoto; Y Kanda; N Hosoda; S Hoshino; O Hazeki; T Katada
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

2.  CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.

Authors:  A Kitanaka; C Ito; E Coustan-Smith; D Campana
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

3.  Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.

Authors:  H Fischer; M Dohlsten; M Lindvall; H O Sjögren; R Carlsson
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

4.  Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation.

Authors:  D G Jackson; J I Bell
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

5.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

6.  Characterization of HLA-D-region antigens by two-dimensional gel electrophoresis. Molecular-genotyping.

Authors:  D J Charron; H O McDevitt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

7.  Tissue-specific expression and developmental regulation of the human fgr proto-oncogene.

Authors:  T J Ley; N L Connolly; S Katamine; M S Cheah; R M Senior; K C Robbins
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

8.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.

Authors:  R Levy; J Dilley; R I Fox; R Warnke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

9.  Novel protein-tyrosine kinase gene (hck) preferentially expressed in cells of hematopoietic origin.

Authors:  S F Ziegler; J D Marth; D B Lewis; R M Perlmutter
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

10.  CD38 ligation results in activation of the Raf-1/mitogen-activated protein kinase and the CD3-zeta/zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes.

Authors:  M Zubiaur; M Izquierdo; C Terhorst; F Malavasi; J Sancho
Journal:  J Immunol       Date:  1997-07-01       Impact factor: 5.422

View more
  14 in total

1.  Abscisic acid released by human monocytes activates monocytes and vascular smooth muscle cell responses involved in atherogenesis.

Authors:  Mirko Magnone; Santina Bruzzone; Lucrezia Guida; Gianluca Damonte; Enrico Millo; Sonia Scarfì; Cesare Usai; Laura Sturla; Domenico Palombo; Antonio De Flora; Elena Zocchi
Journal:  J Biol Chem       Date:  2009-03-30       Impact factor: 5.157

2.  Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease.

Authors:  Franklin R Toapanta; Paula J Bernal; Stephanie Fresnay; Thomas C Darton; Claire Jones; Claire S Waddington; Christoph J Blohmke; Gordon Dougan; Brian Angus; Myron M Levine; Andrew J Pollard; Marcelo B Sztein
Journal:  PLoS Negl Trop Dis       Date:  2015-06-11

3.  Ontogeny, distribution and function of CD38-expressing B lymphocytes in mice.

Authors:  F R Donís-Hernández; R M Parkhouse; L Santos-Argumedo
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

4.  High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.

Authors:  Thijs Booiman; Ferdinand W Wit; Irma Maurer; Davide De Francesco; Caroline A Sabin; Agnes M Harskamp; Maria Prins; Paolo Garagnani; Chiara Pirazzini; Claudio Franceschi; Dietmar Fuchs; Magnus Gisslén; Alan Winston; Peter Reiss; Neeltje A Kootstra
Journal:  Open Forum Infect Dis       Date:  2017-05-25       Impact factor: 3.835

5.  Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma.

Authors:  Jian Hang Lam; Harry Ho Man Ng; Chun Jye Lim; Xin Ni Sim; Fabio Malavasi; Huihua Li; Josh Jie Hua Loh; Khin Sabai; Joo-Kyung Kim; Clara Chong Hui Ong; Tracy Loh; Wei Qiang Leow; Su Pin Choo; Han Chong Toh; Ser Yee Lee; Chung Yip Chan; Valerie Chew; Tong Seng Lim; Joe Yeong; Tony Kiat Hon Lim
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

6.  egc Superantigens Impair Monocytes/Macrophages Inducing Cell Death and Inefficient Activation.

Authors:  Sofia Noli Truant; Mauricio C De Marzi; María B Sarratea; María B Antonoglou; Ana P Meo; Laura V Iannantuono López; María J Fernández Lynch; Marcos Todone; Emilio L Malchiodi; Marisa M Fernández
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561

7.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17

8.  The CD38/CD157 mammalian gene family: An evolutionary paradigm for other leukocyte surface enzymes.

Authors:  Silvia Deaglio; Fabio Malavasi
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

Review 9.  The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy.

Authors:  Yu Jun Wo; Adelia Shin Ping Gan; Xinru Lim; Isabel Shu Ying Tay; Sherlly Lim; Jeffrey Chun Tatt Lim; Joe Poh Sheng Yeong
Journal:  Cells       Date:  2019-12-20       Impact factor: 6.600

10.  Host CD39 Deficiency Affects Radiation-Induced Tumor Growth Delay and Aggravates Radiation-Induced Normal Tissue Toxicity.

Authors:  Alina V Meyer; Diana Klein; Simone de Leve; Klaudia Szymonowicz; Martin Stuschke; Simon C Robson; Verena Jendrossek; Florian Wirsdörfer
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.